Polycystic Ovarian Syndrome Clinical Trial
Official title:
The Effect Of Cabergoline On Follicular Microenvironment Profile In Patients With High Risk Of Ohss
Cabergoline prevents ovarian hyperstimulation syndrome in high risk patients by disrupting follicular fluid hormone microenvironmentally altering the follicular fluid levels of insulin like growth hormone -I (IGF-I), antimullerian hormone (AMH), inhibin B and hepatocyte growth factor (HGF) levels in women with PCOS and high risk of ovarian hyperstimulation syndrome (OHSS).
Dopamine agonists have been proposed as a prophylactic treatment for OHSS in women with high risk of OHSS, however the possible mechanism of action has not been clearly known. In experimental studies, inhibition of vascular endothelial growth factor based pathway was proposed as a possible action of mechanism of dopamine agonists. However the role hepatocyte growth factor (HGF), insulin like growth factor-I (IGF-I), inhibin B and antimullerian hormone (AMH) on cabergoline action in OHSS prevention has not been known. ;
Allocation: Non-Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02244567 -
Effect of Metformin Therapy on Serum Under-carboxylated Osteocalcin Levels in Hyperandrogenic Lean Polycystic Ovarian Syndrome Women
|
Phase 1 | |
Completed |
NCT01653743 -
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
|
Phase 3 | |
Completed |
NCT01672801 -
Nimodipine to Prevent LH Surge During Ovulation Induction: Blinded Placebo-controlled RCT
|
N/A | |
Completed |
NCT00579540 -
Compare Effects of Flax Seed Oil, and Fish Oil on Blood Sugar Levels
|
N/A | |
Terminated |
NCT05084274 -
Optimising Preconceptual Health in Subfertile PCOS Patients Using a Lifestyle Modification Program
|
N/A | |
Completed |
NCT03717935 -
Oral Amino Acid Nutrition to Improve Glucose Excursions in PCOS
|
N/A | |
Withdrawn |
NCT01716429 -
Healthy Eating for Reproductive Health: Greenville
|
N/A | |
Active, not recruiting |
NCT02896452 -
Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
|
||
Recruiting |
NCT05146063 -
LNK in Polycystic Ovary Syndrome With Insulin Resistance
|
||
Recruiting |
NCT06303219 -
Effects of Traditional Moderate Intensity Training and High Intensity Interval Training in Polycystic Ovarian Syndrome
|
N/A | |
Completed |
NCT02869750 -
The Relationship Between Adipokines, Obesity and Insulin Resistance in Women With Polycystic Ovarian Syndrome
|
||
Completed |
NCT01237106 -
In Vitro Maturation (IVM) for Polycystic Ovary Syndrome (PCOS)
|
N/A | |
Completed |
NCT01185704 -
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
|
Phase 3 | |
Recruiting |
NCT04029805 -
Evaluation of a Combination of a Plant Extract and a Probiotic on Glucidic Metabolism in Women With PCOS and High Insulin Levels
|
Phase 1/Phase 2 | |
Completed |
NCT01675843 -
Ovarian Stimulation and Intrauterine Insemination in Women With Polycystic Ovarian Syndrome
|
Phase 4 | |
Completed |
NCT01577017 -
The Effects of Letrozole And Clomiphene Citrate For Induction of Ovulation In Polycystic Ovarian Syndrome(PCOS)
|
Phase 3 | |
Completed |
NCT00478504 -
Letrozole Versus Clomifene Citrate for Ovulation Induction
|
Phase 4 | |
Completed |
NCT05215223 -
Effect of Whole Body Vibration on Insulin Resistance in Females With Polycystic Ovarian Syndrome
|
N/A | |
Completed |
NCT03358199 -
LOD Before IVF/ICSI in PCOS Patients With High AMH
|
N/A | |
Completed |
NCT02436226 -
Use of Low Dose of HCG During Ovulation Induction With CC in Women With CC Resistant PCOS
|
Phase 4 |